Dietary β-cryptoxanthin inhibits N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder carcinogenesis in male ICR mice

Oncology Reports

Volumn 17, Issue 2, 2007, Pages 297-304

  Miyazawa, Katsuhito ^a   Miyamoto, Shingo ^a   Suzuki, Rikako ^a   Yasui, Yumiko ^a   Ikeda, Ryosuke ^a   Kohno, Hiroyuki ^a   Yano, Masamichi ^b   Tanaka, Takuji ^a   Hata, Kazuya ^c   Suzuki, Koji ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF FRUIT TREE SCIENCE   (Japan)

^c Sunplanet Co Ltd   (Japan)

Author keywords

Chemoprevention; Cyclin D1; Urinary bladder carcinogenesis; cryptoxanthin

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOGEN; CRYPTOXANTHIN; CYCLIN D1; N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE; XANTHOPHYLL;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLADDER TUMOR; CHEMICALLY INDUCED DISORDER; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; MOUSE;

ANIMALS; ANTICARCINOGENIC AGENTS; BUTYLHYDROXYBUTYLNITROSAMINE; CARCINOGENS; CYCLIN D1; MALE; MICE; MICE, INBRED ICR; URINARY BLADDER NEOPLASMS; XANTHOPHYLLS;

EID: 33947717052     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.2.297     Document Type: Article

References (50)

1. Coleman MP, Esteve J, Damiecki P, Arslan A and Renard H: Trends in cancer incidence and mortality. IARC Sci Publ 121: 1-806, 1993.
2. Jemal A, Murray T, Ward E, et al: Cancer statistics, 2005. CA Cancer J Clin 55: 10-30, 2005. (Pubitemid 40310185)
3. Ajiki W, Tsukuma H and Oshima A: Cancer incidence and incidence rates in Japan in 1999: estimates based on data from 11 population-based cancer registries. Jpn J Clin Oncol 34: 352-356, 2004. (Pubitemid 43115318)
4. Leppert JT, Shvarts O, Kawaoka K, Lieberman R, Belldegrun AS and Pantuck AJ: Prevention of bladder cancer: a review. Eur Urol 49: 226-234, 2006. (Pubitemid 43197858)
5. Grossman HB: Chemoprevention of bladder cancer. Urology 67: 19-22, 2006.
6. Reddy BS, Hirose Y, Cohen LA, Simi B, Cooma I and Rao CV: Preventive potential of wheat bran fractions against experimental colon carcinogenesis: implications for human colon cancer prevention. Cancer Res 60: 4792-4797, 2000.
7. Tanaka T, Kohno H and Mori H: Chemoprevention of colon carcinogenesis by dietary non-nutritive compounds. Asian Pac J Cancer Prev 2: 165-177, 2001.
8. Glade MJ: Food, nutrition and the prevention of cancer: a global perspective. American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997. Nutrition 15: 523-526, 1999.
9. Faure H, Fayol V, Galabert C, et al: Carotenoids: 1.Metabolism and physiology. Ann Biol Clin (Paris) 57: 169-183, 1999.
10. Tanaka T, Morishita Y, Suzui M, Kojima T, Okumura A and Mori H: Chemoprevention of mouse urinary bladder carcinogenesis by the naturally occurring carotenoid astaxanthin. Carcinogenesis 15: 15-19, 1994. (Pubitemid 24121618)
11. Tanaka T, Makita H, Ohnishi M, Mori H, Satoh K and Hara A: Chemoprevention of rat oral carcinogenesis by naturally occurring xanthophylls, astaxanthin and canthaxanthin. Cancer Res 55: 4095-4064, 1995.
12. Tanaka T, Kawamori T, Ohnishi M, et al : Suppression of azoxymethane-induced rat colon carcinogenesis by dietary administration of naturally occurring xanthophylls astaxanthin and canthaxanthin during the post-initiation phase. Carcinogenesis 16: 2957-2963, 1995. (Pubitemid 26004191)
13. Tsushima M, Maoka T, Katsuyama M, et al: Inhibitory effect of natural carotenoids on Epstein-Barr virus activation activity of a tumor promoter in Raji cells. A screening study for anti-tumor promoters. Biol Pharm Bull 18: 227-233, 1995.
14. Nishino H, Tokuda H, Murakoshi M, et al: Cancer prevention by natural carotenoids. Biofactors 13: 89-94, 2000. (Pubitemid 32107350)
15. Narisawa T, Fukaura Y, Oshima S, Inakuma T, Yano M and Nishino H: Chemoprevention by the oxygenerated carotenoid βcryptoxanthin of N-methylnitrosourea-induced colon carcinogenesis in F344 rats. Jpn J Cancer Res 90: 1061-1065, 1999.
16. Tanaka T, Kohno H, Murakami M, et al : Suppression of azoxymethane-induced colon carcinogenesis in male F344 rats by mandarin juices rich in β-cryptoxanthin and hesperidin. Int J Cancer 88: 146-150, 2000.
17. Kohno H, Taima M, Sumida T, Azuma Y, Ogawa H and Tanaka T: Inhibitory effect of mandarin juice rich in β-cryptoxanthin and hesperidin on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary tumorigenesis in mice. Cancer Lett 174: 141-150, 2001. (Pubitemid 33022673)
18. De Stefani E, Brennan P, Boffetta P, Ronco AL, Mendilaharsu M and Deneo-Pellegrini H: Vegetables, fruits, related dietary antioxidants, and risk of squamous cell carcinoma of the esophagus: a case-control study in Uruguay. Nutr Cancer 38: 23-29, 2000. (Pubitemid 32377939)
19. Goodman MT, McDuffie K, Hernandez B, et al: The association of plasma micronutrients with the risk of cervical atypical squamous cells of undetermined significance (ASCUS). Asian Pac J Cancer Prev 1: 337-345, 2000.
20. Yuan JM, Stram DO, Arakawa K, Lee HP and Yu MC: Dietary cryptoxanthin and reduced risk of lung cancer: the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev 12: 890-898, 2003. (Pubitemid 37151525)
21. Mannisto S, Smith-Warner SA, Spiegelman D, et al : Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies. Cancer Epidemiol Biomarkers Prev 13: 40-48, 2004. (Pubitemid 38116619)
22. Zeegers MP, Goldbohm RA and van den Brandt PA: Are retinol, vitamin C, vitamin E, folate and carotenoids intake associated with bladder cancer risk? Results from the Netherlands Cohort Study. Br J Cancer 85: 977-983, 2001. (Pubitemid 33016000)
23. Hirose Y, Tanaka T, Kawamori T, et al: Chemoprevention of urinary bladder carcinogenesis by the natural phenolic compound protocatechuic acid in rats. Carcinogenesis 16: 2337-2342, 1995.
24. Yang M, Tanaka T, Hirose Y, Deguchi T, Mori H and Kawada Y: Chemopreventive effects of diosmin and hesperidin on N-butyl- N-(4-hydroxybutyl)nitrosamine-induced urinary-bladder carcinogenesis in male ICR mice. Int J Cancer 73: 719-724, 1997. (Pubitemid 127483070)
25. Vinh PQ, Sugie S, Tanaka T, et al: Chemopreventive effects of a flavonoid antioxidant silymarin on N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder carcinogenesis in male ICR mice. Jpn J Cancer Res 93: 42-49, 2002. (Pubitemid 34144711)
26. Sugie S, Vinh PQ, Rahman KM, et al: Suppressive effect of 1,4-phenylene diisothiocyanate on N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder carcinogenesis in male ICR mice. Int J Cancer 117: 524-530, 2005. (Pubitemid 41504539)
27. Petty WJ, Dragnev KH and Dmitrovsky E: Cyclin D1 as a target for chemoprevention. Lung Cancer 41 (Suppl. 1): S155-S161, 2003. (Pubitemid 36819007)
28. Kohno H, Suzuki R, Sugie S, Tsuda H and Tanaka T: Dietary supplementation with silymarin inhibits 3,2′-dimethyl-4-amino-biphenyl-induced prostate carcinogenesis in male F344 rats. Clin Cancer Res 11: 4962-4967, 2005. (Pubitemid 41557218)
29. Suzuki R, Kohno H, Suzui M, et al: An animal model for the rapid induction of tongue neoplasms in human c-Ha-ras protooncogene transgenic rats by 4-nitroquinoline 1-oxide: its potential use for preclinical chemoprevention studies. Carcinogenesis 27: 619-630, 2006. (Pubitemid 43372890)
30. Fukushima S, Murasaki G, Hirose M, Nakanishi K, Hasegawa R and Ito N: Histopathological analysis of preneoplastic changes during N-butyl-N-(4- hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats. Acta Pathol Jpn 32: 243-250, 1982. (Pubitemid 13229315)
31. Otori K, Sugiyama K, Fukushima S and Esumi H: Expression of the cyclin D1 gene in rat colorectal aberrant crypt foci and tumors induced by azoxymethane. Cancer Lett 140: 99-104, 1999. (Pubitemid 29251319)
32. Lee CC, Yamamoto S, Morimura K, et al : Significance of cyclin D1 over-expression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features. Cancer 79: 780-789, 1997. (Pubitemid 27076344)
33. Matsushime H, Roussel MF, Ashmun RA and Sherr CJ: Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65: 701-713, 1991.
34. Motokura T, Bloom T, Kim HG, et al: A novel cyclin encoded by a bcl 1-linked candidate oncogene. Nature 350: 512-515, 1991. (Pubitemid 21912266)
35. Lonardo F, Rusch V, Langenfeld J, Dmitrovsky E and Klimstra DS: Over-expression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development. Cancer Res 59: 2470-2476, 1999. (Pubitemid 29242299)
36. Said TK and Medina D: Cell cyclins and cyclin-dependent kinase activities in mouse mammary tumor development. Carcinogenesis 16: 823-830, 1995.
37. Salim EI, Wanibuchi H, Morimura K, et al: Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl) nitrosamine. Carcinogenesis 21: 195-203, 2000. (Pubitemid 30098703)
38. Yoshida K, Hirose Y, Tanaka T, et al : Inhibitory effects of troglitazone, a peroxisome proliferator-activated receptor gamma ligand, in rat tongue carcinogenesis initiated with 4-nitroquinoline 1-oxide. Cancer Sci 94: 365-371, 2003. (Pubitemid 36626370)
39. Yoshida K, Tanaka T, Hirose Y, et al: Dietary garcinol inhibits 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in rats. Cancer Lett 221: 29-39, 2005. (Pubitemid 40387906)
40. Suwa Y, Takano Y, Iki M, et al : Cyclin D1 protein overexpression is related to tumor differentiation, but not to tumor progression or proliferative activity, in transitional cell carcinoma of the bladder. J Urol 160: 897-900, 1998. (Pubitemid 29479551)
41. Wanibuchi H, Yamamoto S, Chen H, et al: Promoting effects of dimethylarsinic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats. Carcinogenesis 17: 2435-2439, 1996. (Pubitemid 26402244)
42. Jiao D, Eklind KI, Choi CI, Desai DH, Amin SG and Chung FL: Structure-activity relationships of isothiocyanates as mechanism-based inhibitors of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. Cancer Res 54: 4327-4333, 1994. (Pubitemid 24273143)
43. Bertram JS and Bortkiewicz H: Dietary carotenoids inhibit neoplastic transformation and modulate gene expression in mouse and human cells. Am J Clin Nutr 62 (Suppl. 6): S1327-S1336, 1995.
44. Tanaka T: Chemoprevention of human cancer: biology and therapy. Crit Rev Oncol Hematol 25: 139-174, 1997.
45. Mori H, Sugie S, Yoshimi N, Hara A and Tanaka T: Control of cell proliferation in cancer prevention. Mutat Res 428: 291-298, 1999. (Pubitemid 29389700)
46. Shikany JM, Witte JS, Henning SM, et al: Plasma carotenoids and the prevalence of adenomatous polyps of the distal colon and rectum. Am J Epidemiol 145: 552-557, 1997. (Pubitemid 27111224)
47. Comstock GW, Alberg AJ, Huang HY, et al : The risk of developing lung cancer associated with antioxidants in the blood: ascorbic acid, carotenoids, α-tocopherol, selenium and total peroxyl radical absorbing capacity. Cancer Epidemiol Biomarkers Prev 6: 907-916, 1997. (Pubitemid 27481639)
48. Goodman MT, Kiviat N, McDuffie K, et al: The association of plasma micronutrients with the risk of cervical dysplasia in Hawaii. Cancer Epidemiol Biomarkers Prev 7: 537-544, 1998. (Pubitemid 28354118)
49. Gann PH, Ma J, Giovannucci E, et al: Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 59: 1225-1230, 1999. (Pubitemid 29136251)
50. Nomura AM, Lee J, Stemmermann GN and Franke AA: Serum vitamins and the subsequent risk of bladder cancer. J Urol 170: 1146-1150, 2003. (Pubitemid 37108099) Technology